Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer

Recruiting now

Conditions studied: Breast Cancer

In brief

Evaluation of the percentage of transfusions in patients with breast cancer undergoing surgery after preventive treatment with haematinics.

Key facts

Study ID

NCT06883201

Run by

Regina Elena Cancer Institute

People needed

78

Starts

2023-01-31

Expected to finish

2025-06-30

Last updated by the study team

2025-03-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• age > 18 years;
• patients diagnosed with histologically confirmed breast cancer and whether or not they have undergone neoadjuvant chemotherapy;
• patients who are candidates for destructive and reconstructive breast surgery or not;
• Hb values less than or equal to 11 g/dL and/or transferrin saturation less than or equal to 20%;
• written informed consent.

You may not qualify if…

• patients with known allergies to ferric carboxymaltose or its excipients;
• ferritin values greater than 500 ng/ml;
• patients unable to sign consent and comply with procedures.

Where it is running

• "Regina Elena" National Cancer Institute — Rome, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.